GRAND PHARMACEUTICAL

Grand Pharmaceutical

#Financial #More

GRAND PHARMACEUTICAL

Status:
Active


Investments List

Date Company Article Money raised
2022-01-01 Cloudbreak Therapeutics Grand Pharmaceutical investment in Series C - Cloudbreak Therapeutics 130 M USD

More informations about "Grand Pharmaceutical"

Home - Grand Pharma Group

In recent years, Grand Pharma has deployed a series of innovative pharmaceutical products with broad market in the United States, Australia, Germany and other countries. Our Group has established strong partnerships โ€ฆSee details»

Company Introduction - Grand Pharma Group

Grand Pharmaceutical Group Limited (stock code: 00512.HK), abbreviated as โ€œGrand Pharmaโ€, is an international pharmaceutical company of technological innovation, integrating pharmaceutical technology, nuclear medicine anti โ€ฆSee details»

Grand Pharmaceutical Group - Crunchbase Company Profile

Grand Pharmaceutical Group is a pharmaceutical technology firm that also specialises in nuclear medication anti-tumor diagnostic and therapy, cardiovascular and cerebrovascular precise โ€ฆSee details»

International - Grand Pharma Group

International R&D Center in Optics Valley in Wuhan, China is the main R&D body of the Group in the pharmaceutical technology field in China, providing technical support for the R&D of the Groupโ€™s high-end preparation products ... Telix โ€ฆSee details»

Grand Pharmaceutical Group - VentureRadar

Grand Pharmaceutical Group Limited (0512.HK) is a technologically innovative international pharmaceutical enterprise. Its core businesses cover three major areas, namely โ€ฆSee details»

Grand Pharmaceutical Group Company Description - Stock Analysis

Nov 26, 2024 Grand Pharmaceutical Group Limited has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and โ€ฆSee details»

Grand Pharmaceutical - Crunchbase Investor Profile & Investments

Grand Pharmaceutical integrates pharmaceutical technology, nuclear drug anti-tumor diagnosis and treatment, and other services. Grand Pharmaceutical has continuously deployed a โ€ฆSee details»

Sirtex Medical and Grand Pharmaceutical Group Limited

Feb 9, 2022 Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres® Y-90 resin microspheres in China from the National Medical Products โ€ฆSee details»

ITM and Grand Pharma Enter into a Commercialization โ€ฆ

Dec 27, 2021 Grand Pharmaceutical Group Limited (GP) is a diversified global pharmaceutical enterprise sticking to core values and principles of patients-centered, market-oriented and innovation-driven, GP has extensive โ€ฆSee details»

0512.HK - | Stock Price & Latest News | Reuters

About Grand Pharmaceutical Group Ltd (0512.HK) Company Information. ... national and international news to professionals via desktop terminals, the world's media organizations, โ€ฆSee details»

Strategic Development - Grand Pharma Group

An international pharmaceutical company of technological innovation. Grand Pharmaceutical Group Limited (stock code: 00512.HK) sticks with the development concept of โ€œcomprehensive โ€ฆSee details»

DELTA-GP

DELTA GRAND PHARMA (DGP) - as a member of Delta Group- is one of the fastest growing Egyptian companies in the pharmaceutical industry concerned with the discovery, โ€ฆSee details»

00512 Stock Price Quote | Morningstar

3 days ago Grand Pharmaceutical Group Ltd, formerly China Grand Pharmaceutical and Healthcare Holdings Ltd is a drug manufacturer. The company through its subsidiaries โ€ฆSee details»

MI-Based CDMO To Triple Capacity - Grand River Aseptic โ€ฆ

Grand Rapids, September 17, 2021 โ€“ Grand River Aseptic Manufacturing (โ€œGRAMโ€), a leading sterile injectable contract development and manufacturing organization (CDMO) specializing in โ€ฆSee details»

Home - FIP - International Pharmaceutical Federation Home

The International Pharmaceutical Federation (FIP) is the global body representing over 4 million pharmacists and pharmaceutical scientists. We work to meet the world's healthcare needs. โ€ฆSee details»

Pharmaceutical Contract Sales Organizations Market Report 2030

Report Overview. The global pharmaceutical contract sales organizations market was valued at USD 8.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) โ€ฆSee details»

Investor Relations - Grand Pharma Group

May 10, 1999 INVESTOR RELATIONS > Investor Relations > Information Disclosure Investor Relations > Information Disclosure. Information Disclosure Corporate Governance Stock โ€ฆSee details»

Pharmaceutical Market Size, Share & Trends Report, 2030

Pharmaceutical Market Size & Trends. The global pharmaceutical market size was estimated at USD 1,482.0 billion in 2022 and is expected to grow at a compound annual growth rate โ€ฆSee details»

Pharmaceutical Contract Sales Organizations ... - Grand View โ€ฆ

The global pharmaceutical contract sales organizations market size is expected to reach USD 16.3 billion by 2030, registering a CAGR of 8.4% from 2023 to 2030, according to a new report โ€ฆSee details»